Prakt. lékáren. 2012; 8(6): 259-261

Pharmacological support of the early pregnancy in women with lacking corpus luteum

Pavel Trávník
REPROMEDA, s. r. o., Brno

This paper reviews principles of pharmacological support of early pregnancy, including theoretical background of their influence, indications,

and contraindications. Author point out the necessity of estrogen substitution and the contraindication stated by the producent.

pregnancy maintaining, progesteron.

Keywords: corpus luteum, early pregnancy, endometrium transformation, estradiol, estrogens, gestagens, ovary, placenta, pregnancy,

Published: December 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Trávník P. Pharmacological support of the early pregnancy in women with lacking corpus luteum. Praktické lékárenství. 2012;8(6):259-261.
Download citation

References

  1. Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009; 114(6): 1326-1331. Go to original source... Go to PubMed...
  2. Bals-Pratsch M, Al-Hasani S, Schöpper B, Diedrich C, Hoepfner AS, Weiss J, Küpker W, Felberbaum R, Ortmann O, Bauer O, Diedrich K. A simple, inexpensive and effective artificial cycle with exogenous transdermal oestradiol and vaginal progesterone for the transfer of cryopreserved pronucleated human oocytes in women with normal cycles. Hum Reprod. 1999; 14 Suppl 1: 222-230. Go to original source... Go to PubMed...
  3. Bowen A, John VA, Ramirez ME, Good WR. Bioavailability of oestradiol from the Alora (0.1 mg/day) oestradiol matrix transdermal delivery system compared with Estraderm (0.1 mg/day). J Obstet Gynaecol. 1998; 18(6): 575-580. Go to original source... Go to PubMed...
  4. Mašata J. Funkce žlutého tělíska a hormonální terapie v 1. trimestru těhotenství. Moderní gynekologie a porodnictví 2000; 9(3): 549-553.
  5. Michnová L, Rumpík T, Dostál J. Luteální podpora v programu IVF/ET, Česká gynekologie, 2011; 76(2): 104-107. Go to PubMed...




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.